Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1835 1
1843 3
1844 1
1885 1
1892 1
1929 1
1932 1
1943 1
1945 1
1946 2
1947 9
1948 7
1949 3
1950 7
1951 12
1952 7
1953 7
1954 7
1955 6
1956 10
1957 13
1958 6
1959 5
1960 9
1961 5
1962 20
1963 13
1964 25
1965 24
1966 22
1967 22
1968 16
1969 15
1970 13
1971 9
1972 19
1973 20
1974 27
1975 26
1976 35
1977 28
1978 30
1979 37
1980 30
1981 24
1982 43
1983 32
1984 30
1985 19
1986 26
1987 29
1988 17
1989 29
1990 28
1991 40
1992 39
1993 44
1994 21
1995 45
1996 41
1997 43
1998 37
1999 49
2000 42
2001 49
2002 40
2003 46
2004 45
2005 58
2006 52
2007 62
2008 69
2009 56
2010 62
2011 55
2012 73
2013 76
2014 88
2015 95
2016 87
2017 87
2018 96
2019 135
2020 144
2021 160
2022 139
Text availability
Article attribute
Article type
Publication date

Search Results

2,790 results
Results by year
Filters applied: . Clear all
Page 1
Review of primary and secondary erythromelalgia.
Mann N, King T, Murphy R. Mann N, et al. Among authors: king t. Clin Exp Dermatol. 2019 Jul;44(5):477-482. doi: 10.1111/ced.13891. Epub 2019 Jan 4. Clin Exp Dermatol. 2019. PMID: 30609105 Review.
Cryptogenic Organizing Pneumonia.
King TE Jr, Lee JS. King TE Jr, et al. N Engl J Med. 2022 Mar 17;386(11):1058-1069. doi: 10.1056/NEJMra2116777. N Engl J Med. 2022. PMID: 35294814 Review. No abstract available.
Neoadjuvant Endocrine Therapy in Clinical Practice: A Review.
Sella T, Weiss A, Mittendorf EA, King TA, Pilewskie M, Giuliano AE, Metzger-Filho O. Sella T, et al. Among authors: king ta. JAMA Oncol. 2021 Nov 1;7(11):1700-1708. doi: 10.1001/jamaoncol.2021.2132. JAMA Oncol. 2021. PMID: 34499101 Review.
Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition.
Conley RB, Adib G, Adler RA, Åkesson KE, Alexander IM, Amenta KC, Blank RD, Brox WT, Carmody EE, Chapman-Novakofski K, Clarke BL, Cody KM, Cooper C, Crandall CJ, Dirschl DR, Eagen TJ, Elderkin AL, Fujita M, Greenspan SL, Halbout P, Hochberg MC, Javaid M, Jeray KJ, Kearns AE, King T, Koinis TF, Koontz JS, Kužma M, Lindsey C, Lorentzon M, Lyritis GP, Michaud LB, Miciano A, Morin SN, Mujahid N, Napoli N, Olenginski TP, Puzas JE, Rizou S, Rosen CJ, Saag K, Thompson E, Tosi LL, Tracer H, Khosla S, Kiel DP. Conley RB, et al. Among authors: king t. J Bone Miner Res. 2020 Jan;35(1):36-52. doi: 10.1002/jbmr.3877. Epub 2019 Dec 1. J Bone Miner Res. 2020. PMID: 31538675 Free article.
Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.
Lazarus SC, Krishnan JA, King TS, Lang JE, Blake KV, Covar R, Lugogo N, Wenzel S, Chinchilli VM, Mauger DT, Dyer AM, Boushey HA, Fahy JV, Woodruff PG, Bacharier LB, Cabana MD, Cardet JC, Castro M, Chmiel J, Denlinger L, DiMango E, Fitzpatrick AM, Gentile D, Hastie A, Holguin F, Israel E, Jackson D, Kraft M, LaForce C, Lemanske RF Jr, Martinez FD, Moore W, Morgan WJ, Moy JN, Myers R, Peters SP, Phipatanakul W, Pongracic JA, Que L, Ross K, Smith L, Szefler SJ, Wechsler ME, Sorkness CA; National Heart, Lung, and Blood Institute AsthmaNet. Lazarus SC, et al. Among authors: king ts. N Engl J Med. 2019 May 23;380(21):2009-2019. doi: 10.1056/NEJMoa1814917. Epub 2019 May 19. N Engl J Med. 2019. PMID: 31112384 Free PMC article. Clinical Trial.
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update.
Denduluri N, Somerfield MR, Chavez-MacGregor M, Comander AH, Dayao Z, Eisen A, Freedman RA, Gopalakrishnan R, Graff SL, Hassett MJ, King TA, Lyman GH, Maupin GR, Nunes R, Perkins CL, Telli ML, Trudeau ME, Wolff AC, Giordano SH. Denduluri N, et al. Among authors: king ta. J Clin Oncol. 2021 Feb 20;39(6):685-693. doi: 10.1200/JCO.20.02510. Epub 2020 Oct 20. J Clin Oncol. 2021. PMID: 33079579
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial.
Lim SCL, Hor CP, Tay KH, Mat Jelani A, Tan WH, Ker HB, Chow TS, Zaid M, Cheah WK, Lim HH, Khalid KE, Cheng JT, Mohd Unit H, An N, Nasruddin AB, Low LL, Khoo SWR, Loh JH, Zaidan NZ, Ab Wahab S, Song LH, Koh HM, King TL, Lai NM, Chidambaram SK, Peariasamy KM; I-TECH Study Group. Lim SCL, et al. Among authors: king tl. JAMA Intern Med. 2022 Apr 1;182(4):426-435. doi: 10.1001/jamainternmed.2022.0189. JAMA Intern Med. 2022. PMID: 35179551 Clinical Trial.
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab.
Filho OM, Viale G, Stein S, Trippa L, Yardley DA, Mayer IA, Abramson VG, Arteaga CL, Spring LM, Waks AG, Wrabel E, DeMeo MK, Bardia A, Dell'Orto P, Russo L, King TA, Polyak K, Michor F, Winer EP, Krop IE. Filho OM, et al. Among authors: king ta. Cancer Discov. 2021 Oct;11(10):2474-2487. doi: 10.1158/2159-8290.CD-20-1557. Epub 2021 May 3. Cancer Discov. 2021. PMID: 33941592 Free PMC article. Clinical Trial.
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.
Jennings D, Huntwork-Rodriguez S, Henry AG, Sasaki JC, Meisner R, Diaz D, Solanoy H, Wang X, Negrou E, Bondar VV, Ghosh R, Maloney MT, Propson NE, Zhu Y, Maciuca RD, Harris L, Kay A, LeWitt P, King TA, Kern D, Ellenbogen A, Goodman I, Siderowf A, Aldred J, Omidvar O, Masoud ST, Davis SS, Arguello A, Estrada AA, de Vicente J, Sweeney ZK, Astarita G, Borin MT, Wong BK, Wong H, Nguyen H, Scearce-Levie K, Ho C, Troyer MD. Jennings D, et al. Among authors: king ta. Sci Transl Med. 2022 Jun 8;14(648):eabj2658. doi: 10.1126/scitranslmed.abj2658. Epub 2022 Jun 8. Sci Transl Med. 2022. PMID: 35675433
2,790 results